← SynDRA
CAMPTOTHECIN-20-O-PROPIONATE
SynDRA canonical compound SYN0004428 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | TOP1 |
| Mechanism of action | anticancer agent |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- TOP1 INHIBITOR
- DNA topoisomerase I inhibitor
- anticancer agent
Cross-references
Synonyms
- SF-6A
- CZ 48
- UNII-4S145C552U
- 4S145C552U
- SF 6A
- CZ48
- Camptothecin-20(S)-O-propionate
- SCHEMBL1618775
- CHEMBL124162
- DTXSID30173074
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-(1-oxopropoxy)-, (S)-
- RefChem:123161
- DTXCID3095565
- Camptothecin-20(S)-O-propionate hydrate
- orb1700775
- SCHEMBL29395377
- GLXC-10999
- GLXC-22754
- EX-A14037
- AKOS040748207
- DA-62022
- MS-26907
- HY-114668
- CS-0063753
- G17424
- T27113
- cz-48
- CZ-48 trihydrate
- UNII-TR4HR67FMA
- orb2566680
- Camptothecin-20(S)-O-propionate (hydrate)
- T86002
- Camptothecin-20-o-propionate trihydrate
- Camptothecin-20(S)-o-propionate trihydrate
- HY-114668A
- DA-71895
- TR4HR67FMA
Look up CAMPTOTHECIN-20-O-PROPIONATE in the interactive SynDRA portal →